Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Alexion Pharmaceuticals Inc (ALXN)

2014-11-27@07:10:38 ET
Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan (ZAX)

2014-11-27@04:46:04 ET
NICE Issues Final Positive Recommendation for National Commissioning of Soliris(R) (eculizumab) for All Patients with aHUS in England (BIZ)

2014-11-26@12:03:01 ET
Alexion Pharmaceuticals (ALXN) Trading Near $195.50 Resistance Level (FBM)

2014-11-26@07:39:33 ET
Alexion Pharmaceuticals awarded MHLW's ODD for Soliris for treating patients with neuromyelitis optica in Japan (MTO)

2014-11-25@08:13:23 ET
Potential Alexion Pharmaceuticals (ALXN) Trade Could Hit 3.46% Return (FBM)

2014-11-25@06:30:17 ET
Soliris(R) (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Neuromyelitis Optica (BIZ)

2014-11-25@06:21:19 ET
Form 4: Update Filing for Alexion Pharmaceuticals Inc (ALXN) (VKR)

2014-11-25@06:04:24 ET
Form 4: Update Filing for Alexion Pharmaceuticals Inc (ALXN) (VKR)

2014-11-25@05:39:00 ET
Form 4: Update Filing for Alexion Pharmaceuticals Inc (ALXN) (VKR)

2014-11-24@12:46:57 ET
Alexion Pharmaceuticals Bullish Moving Average Crossover Alert (ALXN) (F78)

2014-11-24@04:19:53 ET
Alexion announces favorable data from atypical hemolytic uremic syndrome trials (DTM)

2014-11-21@13:25:42 ET
Alexion Pharmaceuticals (ALXN) Showing Bullish Technicals With Resistance At $195.52 (FBM)

2014-11-20@16:09:37 ET
Alexion Pharmaceuticals (ALXN) Showing Bullish Technicals With Resistance At $196.75 (FBM)

2014-11-20@10:40:47 ET
Alexion Pharmaceuticals Up 21.8% Since SmarTrend Uptrend Call (ALXN) (PSM)

2014-11-19@08:48:06 ET
Alexion Pharmaceuticals (ALXN) Trading Near $185.08 Support Level (FBM)

2014-11-18@15:43:32 ET
Alexion Pharmaceuticals (ALXN) Trading Near $193.51 Resistance Level (FBM)

2014-11-17@09:12:56 ET
Alexion Pharmaceuticals (ALXN) Trading Near $183.03 Support Level (FBM)

2014-11-15@10:00:01 ET
Longer-term Outcome Data from the Largest Prospective Trial of Soliris(R) (eculizumab) in aHUS Underscore the Effectiveness of Ongoing Soliris Treatment (BIZ)

2014-11-14@17:10:26 ET
Watch for Alexion Pharmaceuticals to Potentially Rebound After Falling 2.49% Yesterday (PSM)